These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. I. Behavioral characterization. Kalivas PW, Taylor S, Miller JS. J Pharmacol Exp Ther; 1985 Nov; 235(2):537-43. PubMed ID: 2865357 [Abstract] [Full Text] [Related]
9. Methionine oxidation enhances opioid activity of an enkephalin analog. Kiritsy-Roy JA, Chan SK, Iwamoto ET. Life Sci; 1983 Feb 21; 32(8):889-93. PubMed ID: 6131372 [Abstract] [Full Text] [Related]
10. Evidence for an involvement of the mu-type of opioid receptor in the modulation of learning. Aloyo VJ, Romano AG, Harvey JA. Neuroscience; 1993 Jul 21; 55(2):511-9. PubMed ID: 8397346 [Abstract] [Full Text] [Related]
11. [D-Ala2]-methionine enkephalinamide (DALA): characterization of antinociceptive, cardiovascular, and autonomic nervous system actions in conscious and pentobarbital-anesthetized rats. Randich A, Callahan MF. Pharmacol Biochem Behav; 1986 Sep 21; 25(3):641-50. PubMed ID: 3774831 [Abstract] [Full Text] [Related]
12. Vulnerability to stressor-induced disturbances in self-stimulation from the dorsal and ventral A10 area: differential effects of intraventricular D-Ala2-Met5-enkephalinamide, D-Ala2, N-Me-Phe4, Gly-Ol5-enkephalin, and D-Pen2, D-Pen5-enkephalin administration. Zacharko RM, Maddeaux C, Hebb AL, Mendella PD, Marsh NJ. Brain Res Bull; 1998 Oct 21; 47(3):237-48. PubMed ID: 9865856 [Abstract] [Full Text] [Related]
13. Nonspecific convulsions are induced by morphine but not D-Ala2-methionine-enkephalinamide at cortical sites. Frenk H, Watkins LR, Miller J, Mayer DJ. Brain Res; 1984 May 07; 299(1):51-9. PubMed ID: 6326965 [Abstract] [Full Text] [Related]
14. Opioid modulation of pavlovian learning in rabbits: involvement of sublenticular pathways. Hernandez LL, Valentine JD, Powell DA. Behav Neurosci; 1991 Jun 07; 105(3):431-42. PubMed ID: 1863364 [Abstract] [Full Text] [Related]
15. Medullary substrates of descending spinal inhibition activated by intravenous administration of [D-Ala2]methionine enkephalinamide in the rat. Randich A, Aimone LD, Gebhart GF. Brain Res; 1987 May 19; 411(2):236-47. PubMed ID: 3607431 [Abstract] [Full Text] [Related]
16. Interactions between enkephalin and dopamine in the control of locomotor activity in the rat: a new hypothesis. Agmo A, de Avila N. Pharmacol Biochem Behav; 1985 Apr 19; 22(4):599-603. PubMed ID: 3991768 [Abstract] [Full Text] [Related]
17. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide. Jhamandas K, Sutak M. Br J Pharmacol; 1980 Apr 19; 71(1):201-10. PubMed ID: 7470736 [Abstract] [Full Text] [Related]
18. The effect of intracerebroventricular D-ALA2 methionine enkephalinamide and naloxone on cardiovascular parameters in the cat. Lathers CM, Tumer N, Kraras CM. Life Sci; 1988 Apr 19; 43(26):2287-98. PubMed ID: 3210904 [Abstract] [Full Text] [Related]
19. Intraventricular administration of D-Ala2-Met5-enkephalinamide induces rapid recovery of responding for electrical brain stimulation from the ventral tegmental area following uncontrollable footshock. Maddeaux C, Zacharko RM. Brain Res Bull; 1992 Feb 19; 28(2):337-41. PubMed ID: 1596755 [Abstract] [Full Text] [Related]
20. Cross-sensitization between foot shock stress and enkephalin-induced motor activity. Kalivas PW, Richardson-Carlson R, Van Orden G. Biol Psychiatry; 1986 Aug 19; 21(10):939-50. PubMed ID: 3741911 [Abstract] [Full Text] [Related] Page: [Next] [New Search]